MADRID, SPAIN and CAMBRIDGE, MA–(Marketwired – February 05, 2018) – Oryzon Genomics (ISIN Code: ES0167733015) (MAD: ORY), a public clinical-stage biopharmaceutical company [...]
OTTAWA, ONTARIO–(Marketwired – Feb. 4, 2018) - Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in [...]